Counterfeit medicines are now being found with unnerving frequency, even in the legitimate supply chains of developed markets such as the US and Europe. For manufacturers, regulators and other healthcare stakeholders that raises many issues, including the threat to public safety, the need to improve supply chain security and corporate accountability.
26-Sep-2011 - Ukraine's parliament, the Verkhovna Rada, has voted unanimously in favour of new legislation which will criminalise the production and trafficking of counterfeit drugs.
21-Sep-2011 - Rx-360 has begun its audit sharing programme to increase knowledge about suppliers and the quality of pharmaceutical raw materials.
15-Sep-2011 - The FDA needs additional powers to update its “antiquated, domestically-focused statute” and end the “competitive advantage of non-compliance”, an agency official said.
24-Aug-2011 - Drug counterfeiters are using the Caribbean as a transport hub to ship fake pharmaceutical around the world according to the Antigua Pharmaceutical Society.
24-Aug-2011 - The UAE needs overseas investment to kick-start its pharmaceutical manufacturing sector and end reliance on foreign imports, the DCCI says.
04-Aug-2011 - HP has launched a global authentication service it says will help identify counterfeit and stolen pharmaceuticals.
18-Jul-2011 - Europe has proposed draft distribution guidance in response to globalisation and threats to the pharmaceutical supply chain.
18-Jul-2011 - Physical endurance, traceability and uniqueness are key characteristics for tamper evident devices used in raw material supply, according to Rx-360.
13-Jul-2011 - Congress must grant the FDA additional powers to bring oversight of manufacturing inline with shifts in production practices, according to a report.
04-Jul-2011 - The USP has published a free, online collection of standards to support drug quality, particularly where regulatory resources are limited.
31-May-2011 - Chinese authorities have arrested hundreds of people accused of manufacturing and selling fake pharmaceuticals in the country’s Zhejiang province.
31-May-2011 - The European Union (EU) formally adopted the falsified medicines directive at the weekend, giving member states 18 months to makes the document's anti-counterfeiting track and trace measures into national law.
26-May-2011 - A serialisation system developed by Systech International has been selected by a ‘top 10’ pharma client as a way of meeting Brazil’s Law 11.903 track and trace requirements.
10-May-2011 - The FDA and USP have expanded their collaboration to ensure the quality of medicines by modernising tests and standards.
02-May-2011 - The second draft of Excipact, a set of certification standards for drug excipient producers being developed by the EFCG, FECC, IPEC and PQD, has been sent to industry stakeholders for...
20-Apr-2011 - Pharma, distributors and dispensers have all called for a single, US-wide track-and-trace standard that pre-empts state laws.
16-Mar-2011 - GlaxoSmithKline (GSK) has partnered with Nigeria's National Agency for Food and Drug Administration Control (NAFDAC) to provide a patient SMS verification service for its antibiotic, Ampiclox..
07-Mar-2011 - Efforts to detect fakes with handheld spectrometers appear to be having a positive impact on drug quality in Nigeria according to research by US think-tank the American Enterprise Institute (AEI).
17-Feb-2011 - The European Parliament has approved the falsified medicines directive and described it as a “huge step” in efforts to protect patients.
14-Feb-2011 - Variation between drug batches in developing countries poses “serious clinical implications” and should be tackled by regulators.
10-Feb-2011 - The European Directorate for the Quality of Medicines & HealthCare (EQDM) has begun Phase 2 of its “track & track” anti-counterfeiting strategy and is seeking manufacturer participation.
09-Feb-2011 - The United States Pharmacopeoia (USP) will help regulators in sub-Saharan Africa ensure drug quality in a new scheme designed to boost testing and analysis capacity.
02-Feb-2011 - The EU and US are using substandard medicines as an excuse to tighten IP rules, boosting pharma profits while making it harder for the poor to access drugs, according to...
27-Jan-2011 - Medisafe 1 Technologies is to enter the pharma anti-counterfeiting sector through development of a barcode system.
26-Jan-2011 - Failure to reduce counterfeiting is one of a number of issues slowing healthcare regulation harmonisation in ASEAN.